<?xml version="1.0" encoding="UTF-8"?>
<ref id="R42">
 <label>42</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Tai</surname>
    <given-names>W</given-names>
   </name>, 
   <name name-style="western">
    <surname>He</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>X</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine</article-title>. 
  <source>Cell Mol Immunol</source>
  <year>2020</year>;
  <volume>7</volume>. 
  <pub-id pub-id-type="doi">10.1038/s41423-020-0400-4</pub-id>. [Epub ahead of print: 19 Mar 2020]. 
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32203189?>
 </mixed-citation>
</ref>
